Critical issues and needs in management of primary immunodeficiency diseases in Latin America
A Condino-Neto1, J L Franco, C Trujillo-Vargas
1Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil. condino@icb.usp.br
Insights
Experts highlighted challenges in diagnosing and managing primary immunodeficiency diseases (PIDD) in Latin America. Improving physician training and laboratory access are key to advancing PIDD care in the region.
Area of Science:
- Immunology
- Public Health
Background:
- Primary immunodeficiency diseases (PIDD) diagnosis and management face significant hurdles in Latin America.
- Limited pediatrician and general practitioner training hinders early PIDD suspicion.
- Restricted access to essential laboratory testing, with poor reimbursement for specialized diagnostics, impedes timely diagnosis.
Framework:
- A meeting of experts from six Latin American countries identified critical issues in PIDD care.
- An existing online PIDD Registry Programme for Latin America (since 2009) aims to gather epidemiological data.
- Potential collaborations include establishing a regional laboratory network and enhancing educational programs for PIDD awareness.
Implementation:
- Current PIDD diagnosis relies heavily on specialized centers in major cities.
- Healthcare system variations and reimbursement policies significantly impact treatment accessibility across countries.
- Limited government coverage for screening tests and lack of reimbursement for specialized tests create access barriers.
Implications:
- Enhanced collaboration through a laboratory network and educational initiatives can improve PIDD diagnosis and management.
- Increased PIDD awareness and diagnostic capabilities are crucial for better patient outcomes in Latin America.
- Addressing systemic issues in training, testing, and reimbursement is vital for advancing PIDD care regionally.
Abstract:
Experts from six Latin American countries met to discuss critical issues and needs in the diagnosis and management of primary immunodeficiency diseases (PIDD). The diagnosis of PIDD is generally made following referral to an immunology centre located in a major city, but many paediatricians and general practitioners are not sufficiently trained to suspect PIDD in the first place. Access to laboratory testing is generally limited, and only some screening tests are typically covered by government health programmes. Specialised diagnostic tests are generally not reimbursed. Access to treatment varies by country reflecting differences in healthcare systems and reimbursement policies. An online PIDD Registry Programme for Latin America has been available since 2009, which will provide information about PIDD epidemiology in the region. Additional collaboration across countries appears feasible in at least two areas: a laboratory network to facilitate the diagnosis of PIDD, and educational programmes to improve PIDD awareness. In total, these collaborations should make it possible to advance the diagnosis and management of PIDD in Latin America.
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
American Trypanosomiasis
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Smallpox
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Cryptococcal Meningitis


